Related Experiment Video
Updated: May 13, 2025
Author Spotlight: Innovative Cancer Therapies with Iron Oxide Nanoparticles for Glioblastoma Treatment
Published on: September 27, 2024
The Contribution of Nanomedicine in Ocular Oncology
Margarita Tsoplaktsoglou1, Ellas Spyratou2, Andreas Droulias1
1Medical School, National and Kapodistrian University of Athens, 11527 Athens, Greece.
Abstract:
Nanomedicine is a novel and emerging field that has noted significant progress in both the fields of ophthalmology and cancer treatment. Expanding into ocular oncology, it holds the potential to overcome the limitations of conventional therapies, such as poor drug penetration due to anatomical and physiological ocular barriers and insufficient targeting, which can lead to collateral damage to healthy tissues. By reviewing a series of clinical and preclinical studies, we aim to outline the recent advancements, current trends and future perspectives in nanomedicine for ocular cancer treatment. Beyond improving the existing therapies, like chemotherapy, phototherapies and brachytherapy, nanomedicine enables multimodal applications by combining multiple treatments or integrating imaging for theranostic approaches. Additionally, it paves the way for experimental therapies, such as gene therapy, offering new possibilities for more effective and less invasive treatment strategies in ocular oncology.
Insights
Nanomedicine offers advanced treatments for ocular cancers, overcoming drug delivery challenges and enabling multimodal and experimental therapies for improved patient outcomes.
Area of Science:
- Ophthalmology
- Oncology
- Nanomedicine
Background:
- Nanomedicine shows promise in ophthalmology and cancer treatment.
- Ocular oncology faces challenges with conventional therapies like poor drug penetration and targeting.
- Nanomedicine aims to overcome these limitations in treating eye cancers.
Purpose of the Study:
- Review recent advancements, current trends, and future perspectives of nanomedicine in ocular oncology.
- Highlight nanomedicine's potential to improve existing therapies and enable new treatment strategies.
- Discuss multimodal applications and theranostic approaches in nanomedicine for eye cancer.
Main Methods:
- Review of clinical and preclinical studies on nanomedicine for ocular cancer.
- Analysis of nanomedicine's role in enhancing conventional therapies.
- Exploration of novel applications like gene therapy and theranostics.
Main Results:
- Nanomedicine improves drug penetration and targeting in ocular tissues.
- It enhances existing treatments such as chemotherapy, phototherapy, and brachytherapy.
- Nanomedicine facilitates multimodal treatments and theranostic approaches.
Conclusions:
- Nanomedicine presents a significant advancement for ocular oncology.
- It offers more effective and less invasive treatment strategies for eye cancers.
- Future applications include gene therapy and integrated imaging for improved patient care.
More Related Videos
07:54Surface-enhanced Resonance Raman Scattering Nanoprobe Ratiometry for Detecting Microscopic Ovarian Cancer via Folate Receptor Targeting
Published on: March 25, 2019
08:09Validation of Nanobody and Antibody Based In Vivo Tumor Xenograft NIRF-imaging Experiments in Mice Using Ex Vivo Flow Cytometry and Microscopy
Published on: April 6, 2015
Related Concept Videos
02:57Targeted Cancer Therapies
There are several types of targeted therapies against...
02:49Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...